These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22587408)

  • 1. Recurrence of the acute Charcot foot in diabetes.
    Rudrappa S; Game F; Jeffcoate W
    Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot neuroarthropathy triggered by osteomyelitis and/or surgery.
    Ndip A; Jude EB; Whitehouse R; Prescott M; Boulton AJ
    Diabet Med; 2008 Dec; 25(12):1469-72. PubMed ID: 19046247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering mechanisms of neuroarthropathy following conservative surgery for osteomyelitis.
    Aragón-Sánchez J; Lázaro-Martínez JL; Hernández-Herrero MJ
    Diabet Med; 2010 Jul; 27(7):844-7. PubMed ID: 20636967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot neuroarthropathy: An often overlooked complication of diabetes.
    Botek G; Anderson MA; Taylor R
    Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot neuroarthropathy in diabetes mellitus.
    Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
    Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL; Foster AV; Edmonds ME
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].
    Kamińska A; Kamiński M; Jesionka P; Szymkowiak E; Bronisz A; Zmudzińska M; Junik R; Sikorska Z
    Pol Arch Med Wewn; 2004 Jun; 111(6):709-13. PubMed ID: 15508794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker.
    Christensen TM; Gade-Rasmussen B; Pedersen LW; Hommel E; Holstein PE; Svendsen OL
    J Diabetes Complications; 2012; 26(5):430-4. PubMed ID: 22699112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
    Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
    Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
    Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
    Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of body mass index in acute charcot neuroarthropathy.
    Ross AJ; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid bone destruction after a stress fracture in a diabetic (Charcot) foot.
    Connolly JF; Jacobsen FS
    Nebr Med J; 1985 Dec; 70(12):438-40. PubMed ID: 2867477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Charcot-arthropathy in diabetes mellitus].
    Schoonbeek A; Ottens RL; Lutterman JA
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):60-3. PubMed ID: 11820057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
    Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
    Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Charcot foot.
    Nóbrega MB; Aras R; Netto EM; Couto RD; Marinho AM; da Silva JL; Colares VN; Campelo PL; Nunes MA
    Arch Endocrinol Metab; 2015 Jun; 59(3):226-30. PubMed ID: 26154090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
    Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.